These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13758721)

  • 1. Development of a leukaemia resistant to cyclophosphamide ('Cytoxan').
    LANE M; YANCEY ST
    Nature; 1960 Nov; 188():756-7. PubMed ID: 13758721
    [No Abstract]   [Full Text] [Related]  

  • 2. Some effects of cyclophosphamide (cytoxan) on normal mice and mice with L1210 leukemia.
    LANE M
    J Natl Cancer Inst; 1959 Dec; 23():1347-59. PubMed ID: 14413840
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of the activity of cytoxan against leukemia L1210 in mice.
    VENDITTI JM; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1959 Oct; 19():986-95. PubMed ID: 13841661
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathology of the spread of L1210 leukemia in the central nervous system of mice and effect of treatment with Cytoxan.
    THOMAS LB; CHIRIGOS MA; HUMPHREYS SR; GOLDIN A
    J Natl Cancer Inst; 1962 Jun; 28():1355-89. PubMed ID: 13920822
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of Cytoxan against intracerebrally and subcutaneously inoculated mouse lymphoid leukemia L1210.
    CHIRIGOS MA; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1962 Feb; 22():187-95. PubMed ID: 13879017
    [No Abstract]   [Full Text] [Related]  

  • 6. CHEMOTHERAPY STUDIES WITH VIRUS-INDUCED LEUKEMIA IN MICE.
    GOLDIN A; GLYNN JP; MOLONEY JB; HUMPHREYS SR; CHIRIGOS MA
    Acta Unio Int Contra Cancrum; 1964; 20():157-61. PubMed ID: 14151874
    [No Abstract]   [Full Text] [Related]  

  • 7. A toxicologic and hematologic evaluation of cyclophosphamide (Cytoxan) in experimental animals.
    WHEELER AG; DANSBY D; HAWKINS HC; PAYNE HG; WEIKEL JH
    Toxicol Appl Pharmacol; 1962 May; 4():324-43. PubMed ID: 14006439
    [No Abstract]   [Full Text] [Related]  

  • 8. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS.
    BURCHENAL JH; OETTGEN HF; LYMAN M; PURPLE J
    Acta Unio Int Contra Cancrum; 1964; 20():256-9. PubMed ID: 14151900
    [No Abstract]   [Full Text] [Related]  

  • 9. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 10. The effectiveness of cyclophosphamide (cytoxan) against well established transplanted rodent tumors.
    LANE M
    Cancer Res; 1960 Sep; 20():1269-73. PubMed ID: 13758722
    [No Abstract]   [Full Text] [Related]  

  • 11. STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. II. CHEMOTHERAPY OF VIRUS-INDUCED LYMPHOID LEUKEMIA.
    CHIRIGOS MA; RAUSCHER FJ; KAMEL IA; FANNING GR; GOLDIN A
    Cancer Res; 1963 Nov; 23():1646-50. PubMed ID: 14098904
    [No Abstract]   [Full Text] [Related]  

  • 12. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of cytoxan (cyclophosphamide) on wound healing.
    DESPREZ JD; KIEHN CL
    Plast Reconstr Surg Transplant Bull; 1960 Sep; 26():301-8. PubMed ID: 13722222
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclophosphamide (Cytoxan) in acute leukemia.
    HOOGSTRATEN B
    Cancer Chemother Rep; 1962 Feb; 16():167-71. PubMed ID: 13908759
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophosphamide (cytoxan) in acute leukemia, preliminary report.
    HOOGSTRATEN B
    Cancer Chemother Rep; 1960 Jul; 8():116-9. PubMed ID: 14402990
    [No Abstract]   [Full Text] [Related]  

  • 16. PYRIMIDINES AS THERAPEUTIC AGENTS IN EXPERIMENTAL LEUKAEMIA.
    FELISTOVITCH GI
    Acta Unio Int Contra Cancrum; 1964; 20():230-2. PubMed ID: 14151893
    [No Abstract]   [Full Text] [Related]  

  • 17. Transplantable human tumors in experimental chemotherapy. The effects of Cytoxan on H.S. No. 1 and H.Ep No. 3 in the rat.
    TELLER MN; WOOLLEY GW
    Cancer Res; 1961 Aug; 21():881-4. PubMed ID: 13775794
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential metabolic responses of susceptible and resistant mouse leukemia cells to 8-azaguanine.
    BURK D; LASZLO J; HUNTER J; WIGHT K; WOODS M
    J Natl Cancer Inst; 1960 Jan; 24():57-76. PubMed ID: 13806121
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor activity of cytoxan.
    SUGIURA K; SCHMID FA; SCHMID MM
    Cancer Res; 1961 Nov; 21():1412-20. PubMed ID: 13918230
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the effectiveness of 4',4"-di-2-imidazolin-2-ylterephthalanilides against mouse leukemia L1210 and resistant variants.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1962 Jun; 19():5-11. PubMed ID: 13925303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.